SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
XOMA. Bull or Bear?
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
17367 72 0 XOMA
Emcee:  Olu Emuleomo Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
16492EXTRA!!!! EXTRA!!!!!!!! READ ALL ABOUT IT!!!! LOOK HOW MANY PATIENTS THIS PHYSIBluegreen-11/28/2003
16491patft.uspto.govRobert K.-11/27/2003
16490The active persuit of newer patents by Elsbach has me wondering? patft.uspto.govRobert K.-11/27/2003
16489George, another piece of the puzzle>>>>>>>>http://www.ncBluegreen-11/24/2003
16488George, us beggars can't be so choosy!!!!!!!LOLBluegreen-11/23/2003
16487The combination of the FDA and Xoma refual to fight or say anything are discouraaknahow-11/23/2003
16486No, I have not bought back and until Xoma management becomes more transparent, Iaknahow-11/23/2003
16485George. The company thinks it is even possible that the dose in the meningo triaRobert K.-11/23/2003
16484Blue, you read into my points quick enough. IMO 208 is only a target. If resultsRobert K.-11/23/2003
16483George, you would think that with the Neuprex impressive safety record the new dBluegreen-11/23/2003
16482Nice find. Like the fact that they mentioned expecting to treat the 208. Good aknahow-11/23/2003
16481Bob, here is the writer of that article about the pediatric heart study. I wondBluegreen-11/23/2003
16480George, comments????>>>>>>>http://www.bizjournals.com/dallaBluegreen-11/23/2003
16479Put lotsa nice posts on yahoo today. here is one. >http://www2.conferenceseekRobert K.-11/22/2003
16478The role of CD8+ cells and CD11a in the rejection-reaction of the allogeneic micRobert K.-11/22/2003
16477Anti-LFA-1 therapy induces long-term islet allograft acceptance in the absence oRobert K.-11/22/2003
16476Effects of humanized monoclonal antibody to rhesus CD11a in rhesus monkey cardiaRobert K.-11/22/2003
16475Prolonged inhibition of obliterative airway disease in murine tracheal allograftRobert K.-11/22/2003
16474(note the reference to scid (think about immune deficiency) Anti-CD11a amelioratRobert K.-11/22/2003
16473Essential role of the adhesion receptor LFA-1 for T cell-dependent fulminant hepRobert K.-11/22/2003
16472New monoclonal antibodies in renal trans-plantation. Vincenti F. Kidney TranspRobert K.-11/22/2003
16471Effective treatment of experimental lupus nephritis by combined administration oRobert K.-11/22/2003
16470Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematoRobert K.-11/22/2003
16469Binding of LFA-1 (CD11a) to intercellular adhesion molecule 3 (ICAM-3; CD50) andRobert K.-11/22/2003
16468Association between leukocyte infiltration and development of glomerulosclerosisRobert K.-11/22/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News